Ascendis Pharma A/S (ASND) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ascendis Pharma A/S, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -50.22x | -20.36x | -13.32x | -10.97x | -16.89x | -16.49x |
| P/B Ratio | -67.58x | -72.81x | -44.02x | 24.28x | 7.33x | 8.24x |
| P/S Ratio | 15.90x | 21.17x | 24.05x | 124.97x | 833.09x | 993.40x |
| Profitability | ||||||
| Gross Margin | 85.1% | 87.8% | 83.4% | 76.3% | 54.7% | 100.0% |
| Operating Margin | -18.9% | -76.7% | -170.8% | -1097.9% | -5808.6% | -4755.1% |
| Net Margin | -31.7% | -104.0% | -180.5% | -1139.6% | -4931.6% | -6025.5% |
| EBITDA Margin | -16.5% | -79.8% | -154.2% | -1034.1% | -4688.1% | -5865.2% |
| Liquidity | ||||||
| Current Ratio | 1.04x | 1.17x | 0.95x | 1.29x | 8.03x | 14.02x |
| Quick Ratio | 0.76x | 0.84x | 0.67x | 1.11x | 7.28x | 14.02x |
| Leverage | ||||||
| Debt/Equity | -5.35x | -8.10x | -5.10x | 2.35x | 0.24x | 0.11x |
YoY = year-over-year change. Source: FMP..